MGMT immunohistochemistry (IHC) and exclusion of pancreatic NET (PanNET) patients from treatment with temozolomide-based therapy Meeting Abstract


Authors: Reidy, D. L.; Basturk, O.; Kriplani, A.; Abou-Alfa, G. K.; Jarnagin, W. R.; Allen, P. J.; Saltz, L.; Klimstra, D. S.; Zhang, L. Y.
Abstract Title: MGMT immunohistochemistry (IHC) and exclusion of pancreatic NET (PanNET) patients from treatment with temozolomide-based therapy
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613200564
PROVIDER: wos
Notes: Meeting Abstract: e15169 -- Source: Wos